Option chain shows key data for Schmitt Industries's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Schmitt Industries.

Schmitt Industries (OTC:SMIT) Stock, Option Chain

Schmitt Industries

Schmitt Industries Inc is engaged in propane tank monitoring solutions, precision measurement solutions, and ice cream production and distribution. The Company operates as two reportable segments: the Measurement Segment and the Ice Cream Segment. Xact product line includes satellite-focused remote tank monitoring products and related monitoring services for markets in the IoT environment. The Company also manufactures, wholesales, and retails ice cream and related products.

News

Penny Stocks

Short Sellers

Small Cap

Intraday Update

Markets

Movers

Trading Ideas

ACCD

ALXO

AMAM

AMRN

APGN

ARBK

BBBY

BCAB

BIOL

BIOR

BOXD

BTCS

CALA

CVAC

DATS

DMTK

ELYS

EURN

FREQ

GMVD

HSKA

IDRA

KRUS

LHDX

LODE

NPCE

OTLY

PBLA

PKBO

POET

PRTY

RAIN

RUBY

RYAM

SatixFy Communications Ltd. Ordinary Share

SATX

SMCI

SMIT

SMMT

TMDI

TUEM

VCEL

VORB

VYNE

Why Bed Bath &amp; Beyond Shares Are Trading Higher By 17%? Here Are Other Stocks Moving In Tuesday&#39;s Mid-Day Session

ABVC

AEHR

AEMD

ALGS

ANAB

ATAI

CTMX

EFTR

ELEV

ELOX

EZGO

FATE

GNPX

GRPH

IFBD

IMNM

Kiora Pharmaceuticals, Inc. - Common Stock

KPRX

LABP

MDVL

MEGL

MGAM

MLEC

MULN

NBRV

NXTP

ORTX

OXBR

PALI

SGHT

SPRB

SRTS

SWVL

TANH

TCRR

TIRX

TNXP

VVOS

VYNT

XPEV

ZYXI

Gainers


	Swvl Holdings Corp. (NASDAQ: SWVL) surged 133% to $0.3218. Swvl recently announced the commencement of a strategic review process.


Why Spruce Biosciences Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Friday&#39;s Mid-Day Session

ACON

CEIX

CENN

COSM

DADA

DFLI

DOYU

GLYC

GRRR

HSCS

HTGM

HUYA

JNCE

KALA

KRBP

LGHL

LUCY

MIRO

MMAT

MPAC

NEPT

NERV

PHVS

PROK

QTNT

RNER

SMFL

TGTX

TTOO

UNAM

UNCY

UTRS

VRAX

XRTX

Gainers


	Kala Pharmaceuticals, Inc. (NASDAQ: KALA) shares gained 130.5% to $9.03 after the company announced FDA acceptance of a IND application for its KPI-012 for the treatment of persistent corneal epithelial defect.


Why Shares Of Chinese Companies Are Trading Lower? Here Are 54 Stocks Moving In Wednesday&#39;s Mid-Day Session

SCHMITT INDUSTRIES INC by Schmitt Industries, Inc.

Schmitt Industries Inc

SMITHSON INVESTMENT TRUST by Smithson Investment Trust PLC.

Smith & Nephew PLC

SMITH & NEPHEW PLC ORD by Smith & Nephew PLC

Smith & Wesson Brands, Inc. - Common Stock

Smith & Wesson Brands Inc

Smith Douglas Homes Corp. Class A Common Stock

Smith Douglas Homes Corp

Smith Micro Software, Inc. - Common Stock

Smith Micro Software Inc

Smith-Midland Corp

Smithfield Foods Inc

Smiths Group PLC

SMITHS GROUP PLC S/ADR by Smiths Group Plc

SMITHS NEWS PLC UNSP/ADR by SMITHS NEWS PLC

Smiths News PLC

<h3>Gainers</h3>
<ul>
<li>D-Wave Quantum (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QBTS#NYSE">QBTS</a>) shares rose 20.3% to $1.61 during Monday's pre-market session. The company's market cap stands at $179.6 million. </li>
<li>National Instruments (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NATI#NASDAQ">NATI</a>) stock increased by 17.02% to $47.01. The market value of their outstanding shares is at $6.1 billion. </li>
<li>WISeKey Intl Hldg (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WKEY#NASDAQ">WKEY</a>) stock increased by 11.48% to $2.33. The market value of their outstanding shares is at $38.2 million. </li>
<li>ClearSign Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLIR#NASDAQ">CLIR</a>) shares rose 11.21% to $0.76. The company's market cap stands at $28.8 million. </li>
<li>Schmitt Industries (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMIT#NASDAQ">SMIT</a>) shares rose 10.31% to $0.42. The company's market cap stands at $1.6 million. </li>
<li>SoundHound AI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOUN#NASDAQ">SOUN</a>) stock rose 9.99% to $1.21. The market value of their outstanding shares is at $239.4 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>BigBear.ai Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBAI#NYSE">BBAI</a>) shares decreased by 16.1% to $2.56 during Monday's pre-market session. The company's market cap stands at $324.9 million. </li>
<li>PAR Technology (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PAR#NYSE">PAR</a>) stock fell 10.55% to $27.01. The market value of their outstanding shares is at $737.0 million. </li>
<li>American Virtual Cloud (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVCT#NASDAQ">AVCT</a>) stock fell 9.42% to $0.77. The company's market cap stands at $25.1 million. </li>
<li>Cemtrex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CETX#NASDAQ">CETX</a>) stock declined by 9.21% to $0.15. The market value of their outstanding shares is at $4.1 million. </li>
<li>Blackboxstocks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLBX#NASDAQ">BLBX</a>) shares fell 7.91% to $0.45. The market value of their outstanding shares is at $5.9 million. </li>
<li>Maxeon Solar Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAXN#NASDAQ">MAXN</a>) stock fell 7.82% to $20.59. The market value of their outstanding shares is at $926.2 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AVCT

BBAI

BLBX

CETX

CLIR

Maxeon Solar Technologies, Ltd. - Ordinary Shares

MAXN

NATI

QBTS

SOUN

WKEY

12 Information Technology Stocks Moving In Monday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Sotera Health Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/shc#NASDAQ">SHC</a>) shares jumped 92% to $16.59 after the company announced its subsidiaries have reached agreements to settle the Ethylene Oxide cases pending against Sterigenics. Sterigenics will pay the company $408 million to settle the claims.</li>
<li>Party City Holdco Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/prty#NYSE">PRTY</a>) gained 54% to $0.3193 following an Axios report suggesting The Franchise Group could be looking at acquiring the company.</li>
<li>Panbela Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pbla#NASDAQ">PBLA</a>) shares rose 51.1% to $0.1224 after gaining 4% on Monday.</li>
<li>VYNE Therapeutics Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vyne#NASDAQ">VYNE</a>) climbed 50.5% to $0.2892 after the company announced the first vitiligo patient was dosed in a Phase 1a/b clinical trial of VYN201.</li>
<li>Elys Game Technology, Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/elys#NASDAQ">ELYS</a>) jumped 49.5% to $0.6276.</li>
<li>Boxed, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/boxd#NYSE">BOXD</a>) gained 36.6% to $0.5191 after the company announced its Spresso Saas modular solution platform is now available on Google Cloud.</li>
<li>Biora Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bior#NASDAQ">BIOR</a>) rose 35% to $2.85. HC Wainwright &amp; Co. maintained Biora Therapeutics with a Buy.</li>
<li>DermTech, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dmtk#NASDAQ">DMTK</a>) shares climbed 32.6% to $2.88 after DermTech announced the foundational assay of its DermTech Melanoma Test (DMT) is recommended for coverage by TRICARE.</li>
<li>DatChat, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dats#NASDAQ">DATS</a>) gained 31.7% to $0.48 after the company announced a $2 million stock repurchase plan.</li>
<li>POET Technologies Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/poet#NASDAQ">POET</a>) gained 31.3% to $4.2750.</li>
<li>Jianzhi Education Technology Group Company Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jz#NASDAQ">JZ</a>) gained 30% to $1.5657.</li>
<li>Rubius Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ruby#NASDAQ">RUBY</a>) jumped 29.4% to $0.2349.</li>
<li>Oak Street Health, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/osh#NYSE">OSH</a>) gained 28.4% to $28.99 as CVS Health is reportedly exploring an acquisition of primary care center operator.</li>
<li>BTCS Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/btcs#NASDAQ">BTCS</a>) jumped 28.2% to $1.3199 after the company launched a private beta of its digital asset analytic and staking-as-a-service platform StakeSeeker.</li>
<li>Frontline plc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fro#NYSE">FRO</a>) rose 27.1% to $14.40. Frontline announced termination of combination agreement with Euronav.</li>
<li>Schmitt Industries, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/smit#NASDAQ">SMIT</a>) gained 27.1% to $0.3879.</li>
<li>Prenetics Global Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pre#NASDAQ">PRE</a>) gained 25.6% to $2.3880 after the company announced its ACT Genomics received clearance from the FDA for ACTOnco.</li>
<li>NeuroPace, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/npce#NASDAQ">NPCE</a>) jumped 25.2% to $2.04. NeuroPace announced preliminary unaudited Q4 revenue of $12.8 million and FY22 revenue of $45.5 million.</li>
<li>Bright Health Group, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bhg#NYSE">BHG</a>) gained 24% to $0.8050 after the company announced it increased 2023 Enterprise Revenue guidance to $3.4 - $3.6 billion.</li>
<li>Frequency Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/freq#NASDAQ">FREQ</a>) rose 24% to $4.13.</li>
<li>Ambrx Biopharma Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amam#NASDAQ">AMAM</a>) jumped 23.5% to $2.62.</li>
<li>Accolade, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/accd#NASDAQ">ACCD</a>) rose 23.5% to $9.58 after the company reported better-than-expected Q3 EPS and sales results and issued FY23 revenue guidance above estimates.</li>
<li>Kura Sushi USA, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/krus#NASDAQ">KRUS</a>) gained 21.4% to $52.24. Kura Sushi recently reported worse-than-expected Q1 EPS and sales results.</li>
<li>Titan Medical Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tmdi#NASDAQ">TMDI</a>) rose 20.4% to $1.1195.</li>
<li>Tuesday Morning Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tuem#NASDAQ">TUEM</a>) gained 19.4% to $0.74.</li>
<li>Summit Therapeutics Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/smmt#NASDAQ">SMMT</a>) climbed 17.8% to $4.4438. Summit Therapeutics said on January 6, 2023, the company held meeting to vote on increase number of authorized shares of common stock by 650 million shares.</li>
<li>Amarin Corporation plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amrn#NASDAQ">AMRN</a>) gained 17.2% to $1.7350 after the company reported preliminary Q4 and FY22 revenue results above estimates.</li>
<li>Bed Bath &amp; Beyond Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bbby#NASDAQ">BBBY</a>) rose 17.1% to $1.8975 despite the company turning in worse-than-expected financial results.</li>
<li>Satixfy Communications Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/satx#NYSE">SATX</a>) gained 16.3% to $7.49.</li>
<li>Versus Systems Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vs#NASDAQ">VS</a>) rose 15.3% to $0.6990 after jumping over 16% on Monday.</li>
<li>CureVac N.V. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cvac#NASDAQ">CVAC</a>) gained 14.8% to $11.90.</li>
<li>Vericel Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vcel#NASDAQ">VCEL</a>) rose 14% to $27.25 after the company reported preliminary FY22 revenue results.</li>
<li>Rain Oncology Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rain#NASDAQ">RAIN</a>) gained 13.9% to $13.23.</li>
<li>Oatly Group AB (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/otly#NASDAQ">OTLY</a>) jumped 12.3% to $2.6750 after the company announced an expansion of its partnership with Reitan to feature oat drink in coffee machines in its 7-Eleven and Pressbyr&aring;n convenience stores across Sweden.</li>
<li>Comstock Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/lode#NYSE">LODE</a>) shares rose 11.9% to $0.4498.</li>
<li>Heska Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hska#NASDAQ">HSKA</a>) gained 10.3% to $74.34. Heska CEO and President Kevin S Wilson bought a total of 11,018 shares at an average price of $58.62.</li>
</ul>
<h3>
Losers</h3>
<ul>
<li>Peak Bio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pkbo#NASDAQ">PKBO</a>) dropped 58.2% to $2.09.</li>
<li>BioAtla, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bcab#NASDAQ">BCAB</a>) shares fell 46.2% to $4.1550 after the company provided clinical program updates and upcoming 2023 milestones.</li>
<li>BIOLASE, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/biol#NASDAQ">BIOL</a>) fell 46.5% to $0.3705 after the company announced pricing of $9.75 million offering.</li>
<li>Rayonier Advanced Materials Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ryam#NYSE">RYAM</a>) fell 30.6% to $6.35. RBC Capital downgraded Rayonier Adv</li>
<li>Materials from Outperform to Sector Perform and lowered the price target from $9 to $8.</li>
<li>Calithera Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cala#NASDAQ">CALA</a>) dipped 25.3% to $0.4931. Calithera Biosciences shares dipped around 82% on Monday after its board of directors determined to dissolve the company and liquidate its assets. Also, the company will discontinue all clinical development programs and reduce its workforce.</li>
<li>Idera Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/idra#NASDAQ">IDRA</a>) fell 17.6% to $0.5510.</li>
<li>Euronav NV (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/eurn#NYSE">EURN</a>) shares fell 16.9% to $13.24.</li>
<li>IsoPlexis Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/iso#NASDAQ">ISO</a>) dipped 15.3% to $1.33.</li>
<li>Lucira Health, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lhdx#NASDAQ">LHDX</a>) dropped 14.8% to $0.3438.</li>
<li>Midatech Pharma plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mtp#NASDAQ">MTP</a>) fell 14.7% to $0.81.</li>
<li>Berkeley Lights, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bli#NASDAQ">BLI</a>) dropped 13.7% to $2.2850 after the company issued FY22 revenue guidance below analyst estimates.</li>
<li>ALX Oncology Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/alxo#NASDAQ">ALXO</a>) fell 12% to $9.22.</li>
<li>Virgin Orbit Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vorb#NASDAQ">VORB</a>) fell 11.7% to $1.70. Virgin Orbit shared its readiness for the Start Me Up mission for a historic U.K. launch on January 9.</li>
<li>G Medical Innovations Holdings Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gmvd#NASDAQ">GMVD</a>) fell 10.9% to $3.9812 after jumping 42% on Monday.</li>
<li>Argo Blockchain plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/arbk#NASDAQ">ARBK</a>) fell 9.5% to $1.2850.</li>
<li>Super Micro Computer, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/smci#NASDAQ">SMCI</a>) fell 8.4% to $77.67 after Spruce Point Management issued a bearish report on the stock.</li>
<li>Apexigen, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/apgn#NASDAQ">APGN</a>) fell 7.2% to $1.67 after gaining around 91% on Monday.</li>
<li>Box, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/box#NYSE">BOX</a>) fell 6.3% to $27.96. RBC Capital downgraded Box from Sector Perform to Underperform and lowered the price target from $28 to $24.</li>
</ul>
Also Check This Out <a href="https://www.benzinga.com/markets/cryptocurrency/23/01/30355338/ethereum-remains-above-this-key-level-aptos-emerges-as-top-gainer"> Ethereum Remains Above This Key Level; Aptos Emerges As Top Gainer </a>

Why Bed Bath & Beyond Shares Are Trading Higher By 17%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

<h3>Gainers</h3>
<ul>
<li>DatChat (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DATS#NASDAQ">DATS</a>) shares moved upwards by 30.9% to $0.47 during Tuesday's regular session. The current volume of 5.7 million shares is 3742.3% of DatChat's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $9.6 million. </li>
<li>BTCS (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTCS#NASDAQ">BTCS</a>) shares moved upwards by 26.21% to $1.27. As of 12:30 EST, this security is trading at a volume of 436.5K shares, making up 992.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $16.6 million. </li>
<li>Schmitt Industries (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMIT#NASDAQ">SMIT</a>) shares rose 22.82% to $0.38. Trading volume for this security as of 12:30 EST is 268.5K, which is 169.5% of its average full-day volume over the last 100 days. The company's market cap stands at $1.4 million. </li>
<li>Iris Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IREN#NASDAQ">IREN</a>) shares rose 20.22% to $1.59. Iris Energy's stock is trading at a volume of 250.9K shares as of 12:30 EST. This is 83.7% of its average full-day volume over the last 100 days. The company's market cap stands at $87.2 million. </li>
<li>Neonode (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEON#NASDAQ">NEON</a>) shares rose 17.46% to $6.73. As of 12:30 EST, this security is trading at a volume of 225.0K shares, making up 170.3% of its average full-day volume over the last 100 days. The company's market cap stands at $91.3 million. </li>
<li>MicroCloud Hologram (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOLO#NASDAQ">HOLO</a>) shares moved upwards by 17.23% to $6.53. Trading volume for this security as of 12:30 EST is 277.3K, which is 90.4% of its average full-day volume over the last 100 days. The company's market cap stands at $331.8 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Blackboxstocks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLBX#NASDAQ">BLBX</a>) shares decreased by 16.3% to $0.41 during Tuesday's regular session. The market value of their outstanding shares is at $5.4 million. </li>
<li>Argo Blockchain (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARBK#NASDAQ">ARBK</a>) stock fell 9.51% to $1.28. Trading volume for this security as of 12:30 EST is 186.8K, which is 31.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $61.4 million. </li>
<li>OMNIQ (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OMQS#NASDAQ">OMQS</a>) stock declined by 9.15% to $4.54. The company's market cap stands at $34.9 million. </li>
<li>TDCX (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDCX#NYSE">TDCX</a>) stock decreased by 8.9% to $11.98. The company's market cap stands at $1.7 billion. </li>
<li>Arqit Quantum (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARQQ#NASDAQ">ARQQ</a>) shares decreased by 8.7% to $2.52. As of 12:30 EST, this security is trading at a volume of 377.8K shares, making up 68.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $309.1 million. </li>
<li>Oblong (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OBLG#NASDAQ">OBLG</a>) shares declined by 7.84% to $2.47. The current volume of 57.6K shares is 22.6% of Oblong's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $5.0 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ARQQ

MicroCloud Hologram Inc. - Ordinary Shares

HOLO

IREN

NEON

OBLG

OMQS

TDCX

12 Information Technology Stocks Moving In Tuesday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>Vislink Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VISL#NASDAQ">VISL</a>) shares moved upwards by 9.8% to $0.51 during Monday's after-market session. This security traded at a volume of 56.2K shares come close, making up 20.1% of its average volume over the last 100 days. The company's market cap stands at $24.0 million. </li>
<li>TeraWulf (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WULF#NASDAQ">WULF</a>) shares increased by 7.16% to $0.75. The market value of their outstanding shares is at $108.7 million. </li>
<li>Schmitt Industries (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMIT#NASDAQ">SMIT</a>) stock moved upwards by 5.04% to $0.32. The company's market cap stands at $1.2 million. </li>
<li>AEye (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIDR#NASDAQ">LIDR</a>) stock rose 4.87% to $0.6. The company's market cap stands at $96.6 million. </li>
<li>Sobr Safe (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOBR#NASDAQ">SOBR</a>) shares rose 4.8% to $0.92. The company's market cap stands at $13.3 million. </li>
<li>Zepp Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZEPP#NYSE">ZEPP</a>) shares increased by 4.44% to $1.88. The market value of their outstanding shares is at $117.0 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Greenidge Generation Hldg (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GREE#NASDAQ">GREE</a>) stock fell 5.6% to $0.51 during Monday's after-market session. The market value of their outstanding shares is at $22.8 million. </li>
<li>Akerna (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KERN#NASDAQ">KERN</a>) stock declined by 5.55% to $0.86. The market value of their outstanding shares is at $3.8 million. </li>
<li>MicroCloud Hologram (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOLO#NASDAQ">HOLO</a>) stock declined by 5.39% to $5.27. The company's market cap stands at $267.7 million. </li>
<li>Borqs Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRQS#NASDAQ">BRQS</a>) shares decreased by 4.85% to $0.27. At the close, Borqs Technologies's trading volume reached 61.8K shares. This is 2.5% of its average volume over the last 100 days. The market value of their outstanding shares is at $4.9 million. </li>
<li>WM Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAPS#NASDAQ">MAPS</a>) shares declined by 3.61% to $1.07. The company's market cap stands at $97.3 million. </li>
<li>WeTrade Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WETG#NASDAQ">WETG</a>) stock fell 3.34% to $0.46. Today's trading volume for this security ended up closing at 102.2K shares, which is 7.4 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $90.5 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Borqs Technologies, Inc. - Ordinary Shares

BRQS

GREE

KERN

LIDR

MAPS

SOBR

VISL

WETG

WULF

ZEPP

12 Information Technology Stocks Moving In Monday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Swvl Holdings Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/swvl#NASDAQ">SWVL</a>) surged 133% to $0.3218. Swvl recently announced the commencement of a strategic review process.</li>
<li>Spruce Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sprb#NASDAQ">SPRB</a>) shares jumped 100.8% to $2.51. Spruce Biosciences and Kaken Pharmaceutical reported an exclusive licensing agreement to develop and commercialize Tildacerfont for CAH in Japan.</li>
<li>MedAvail Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mdvl#NASDAQ">MDVL</a>) gained 54% to $0.4745. MedAvail Holdings, during November, posted a Q3 loss of $0.15 per share.</li>
<li>CytomX Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ctmx#NASDAQ">CTMX</a>) climbed 46.4% to $2.6198. CytomX and Moderna reported a strategic research collaboration for mRNA-based conditionally activated therapeutics.</li>
<li>Zomedica Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/zom#NYSE">ZOM</a>) gained 38% to $0.2649 after Dawson James initiated coverage on the stock with a Buy rating and a $6 price target.</li>
<li>Aehr Test Systems (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aehr#NASDAQ">AEHR</a>) shares jumped 34.8% to $23.28 after the company reported better-than-expected Q2 EPS and sales results and announced it received a follow-on production order from its second major silicon carbide semiconductor customer for an additional production FOX-XP multi-wafer test and burn-in system configured with Aehr&#39;s fully integrated and automated WaferPak Aligner.</li>
<li>Tantech Holdings Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tanh#NASDAQ">TANH</a>) gained 26.8% to $3.1980. Tantech Hldgs recently posted H1 sales of $27.00 million.</li>
<li>Tonix Pharmaceuticals Holding Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tnxp#NASDAQ">TNXP</a>) gained 26% to $0.7555.</li>
<li>Aligos Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/algs#NASDAQ">ALGS</a>) jumped 23.2% to $1.22 after Jefferies upgraded the stock from Hold to Buy and raised its price target from $2.5 to $3.</li>
<li>Infobird Co., Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ifbd#NASDAQ">IFBD</a>) surged 23% to $0.9476.</li>
<li>Kidpik Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pik#NASDAQ">PIK</a>) gained 22.2% to $0.8799.</li>
<li>Sight Sciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sght#NASDAQ">SGHT</a>) gained 21.8% to $14.39. Stifel upgraded Sight Sciences from Hold to Buy and raised the price target from $10 to $15.</li>
<li>Mobile Global Esports Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mgam#NASDAQ">MGAM</a>) rose 21.5% to $1.30 after gaining over 21% on Thursday.</li>
<li>Schmitt Industries, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/smit#NASDAQ">SMIT</a>) gained 21.3% to $0.3399.</li>
<li>EZGO Technologies Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ezgo#NASDAQ">EZGO</a>) gained 19.5% to $0.99.</li>
<li>Zynex, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zyxi#NASDAQ">ZYXI</a>) gained 19.4% to $16.89. Piper Sandler upgraded Zynex from Neutral to Overweight and raised the price target from $10 to $18.</li>
<li>CureVac N.V. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cvac#NASDAQ">CVAC</a>) surged 18.2% to $7.54 after the company announced data on joint COVID-19 and flu mRNA vaccine development programs.</li>
<li>World Wrestling Entertainment, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wwe#NYSE">WWE</a>) rose 17.6% to $84.69 after Vince McMahon announced he has taken actions in support of a plan for WWE to undertake a review of strategic alternatives and capture unique opportunity to maximize long-term value.</li>
<li>Oxbridge Re Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/oxbr#NASDAQ">OXBR</a>) gained 16.8% to $1.80.</li>
<li>Sensus Healthcare, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/srts#NASDAQ">SRTS</a>) jumped 16.6% to $8.60. Sensus Healthcare expects Q4 sales to exceed $13 million.</li>
<li>TCR2 Therapeutics Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tcrr#NASDAQ">TCRR</a>) gained 16.5% to $1.27. Piper Sandler maintained TCR2 Therapeutics with an Overweight and raised the price target from $8 to $10.</li>
<li>Magic Empire Global Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/megl#NASDAQ">MEGL</a>) rose 13.9% to $2.6199 after climbing 75% on Thursday.</li>
<li>Mullen Automotive, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/muln#NASDAQ">MULN</a>) gained 13.8% to $0.4762.</li>
<li>Aethlon Medical, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aemd#NASDAQ">AEMD</a>) shares rose 13.2% to $0.39. Aethlon Medical, last month, posted a Q2 loss of $0.18 per share.</li>
<li>Duck Creek Technologies, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dct#NYSE">DCT</a>) gained 12.5% to $12.69 following Q1 results.</li>
<li>Amarin Corporation plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amrn#NASDAQ">AMRN</a>) gained 12.3% to $1.4150 after Jefferies upgraded the stock from Hold to Buy and raised its price target from $1.3 to $3.</li>
<li>JinkoSolar Holding Co., Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/jks#NYSE">JKS</a>) rose 11.8% to $44.69.</li>
<li>Immunome, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/imnm#NASDAQ">IMNM</a>) shares gained 11.2% to $5.24 after the company and AbbVie announced a strategic collaboration to discover multiple novel oncology targets. Immunome will receive a $30 million upfront payment with the potential for milestones and royalties.</li>
<li>Oriental Culture Holding LTD (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ocg#NASDAQ">OCG</a>) gained 10% to $0.55.</li>
<li>eFFECTOR Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/eftr#NASDAQ">EFTR</a>) rose 8% to $0.5958. eFFECTOR Therapeutics provided an update on its ongoing clinical development programs for zotatifin, in Phase 2 expansion cohorts for estrogen receptor-positive breast cancer (ER+ BC) and KRAS non-small cell lung cancer (KRAS NSCLC) as well as Phase 1 development for COVID-19, and tomivosertib, in Phase 2b trial for non-small cell lung cancer (NSCLC) in combination with pembrolizumab.</li>
</ul>
<h3>
Losers</h3>
<ul>
<li>Fate Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fate#NASDAQ">FATE</a>) shares dipped 62.2% to $4.16 after the company announced termination</li>
<li>of its collaboration agreement with Janssen, pipeline prioritization, next-generation programs and key 2023 initiatives.</li>
<li>Graphite Bio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/grph#NASDAQ">GRPH</a>) fell 41.3% to $1.7950 after the company reported it is voluntarily pausing the Phase 1/2 CEDAR study of nulabeglogene autogedtemcel (nula-cel) for sickle cell disease due to a serious adverse event in the first patient dosed with nula-cel.</li>
<li>Atai Life Sciences N.V. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/atai#NASDAQ">ATAI</a>) fell 41.3% to $1.5450 after the company announced Perception Neuroscience&#39;s Phase 2a clinical trial did not meet its primary endpoint.</li>
<li>Nabriva Therapeutics plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nbrv#NASDAQ">NBRV</a>) dropped 33.4% to $1.5238 after the company issued a corporate update.</li>
<li>AnaptysBio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/anab#NASDAQ">ANAB</a>) declined 28.8% to $21.49 after the company announced portfolio update across best-in-class immune cell modulating antibodies. Raymond James downgraded AnaptysBio from Outperform to Market Perform.</li>
<li>NextPlay Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nxtp#NASDAQ">NXTP</a>) fell 25.9% to $1.63. NextPlay announced a 1-for-20 reverse stock split effective January 6, 2023.</li>
<li>Landos Biopharma, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/labp#NASDAQ">LABP</a>) fell 24.7% to $0.4086 after Jefferies downgraded the stock from Hold to Underperform and lowered its price target from $0.20 to $0.10.</li>
<li>AMTD Digital Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hkd#NYSE">HKD</a>) shares fell 24.5% to $22.54 after surging around 200% on Thursday.</li>
<li>Elevation Oncology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/elev#NASDAQ">ELEV</a>) declined 20% to $0.8395 after the company reported pipeline prioritization, realignment of resources to advance EO-3021 and CEO transition.</li>
<li>Tian Ruixiang Holdings Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tirx#NASDAQ">TIRX</a>) dropped 20% to $2.60.</li>
<li>Vivos Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vvos#NASDAQ">VVOS</a>) dropped 19.1% to $1.52. Vivos Therapeutics priced an $8 million private placement at $1.20 per unit.</li>
<li>Moolec Science SA (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mlec#NASDAQ">MLEC</a>) declined 17.8% to $4.50.</li>
<li>Genprex, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gnpx#NASDAQ">GNPX</a>) dropped 17.6% to $1.4225.</li>
<li>Bed Bath &amp; Beyond Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bbby#NASDAQ">BBBY</a>) fell 16.9% to $1.4050 after dropping around 30% on Thursday. The company said it will miss its 10-Q filing deadline for the quarter ending Nov 26, 2022 and has also concluded that there is substantial doubt about its ability to continue as a going concern.</li>
<li>Kiora Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/kprx#NASDAQ">KPRX</a>) declined 15.4% to $3.90.</li>
<li>XPeng Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/xpev#NYSE">XPEV</a>) fell 15% to $10.11.</li>
<li>Palisade Bio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pali#NASDAQ">PALI</a>) dropped 14.8% to $2.76.</li>
<li>Eloxx Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/elox#NASDAQ">ELOX</a>) fell 14.5% to $3.6913.</li>
<li>The Greenbrier Companies, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gbx#NYSE">GBX</a>) dropped 14% to $30.00 after the company reported Q1 earnings results and issued guidance.</li>
<li>Kura Sushi USA, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/krus#NASDAQ">KRUS</a>) fell 13% to $42.11 after the company reported worse-than-expected Q1 EPS and sales results.</li>
<li>InMed Pharmaceuticals Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/inm#NASDAQ">INM</a>) fell 13% to $1.68 after declining over 11% on Thursday.</li>
<li>Vyant Bio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vynt#NASDAQ">VYNT</a>) fell 12.3% to $1.06. Vyant Bio shares jumped around 57% on Thursday after the company engaged LifeSci Capital as its advisor to explore strategic alternatives.</li>
<li>Orchard Therapeutics plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ortx#NASDAQ">ORTX</a>) shares fell 11.3% to $0.5583. Orchard Therapeutics shares gained around 22% on Thursday after the company announced FDA clearance of the IND application for OTL-203 in MPS-IH.</li>
<li>ABVC BioPharma, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/abvc#NASDAQ">ABVC</a>) fell 11.2% to $0.9501. ABVC BioPharma shares climbed over 72% on Thursday after the company announced the FDA approved its IND submission, allowing the company to proceed with the clinical study of ABV-1519 for the treatment of non-small cell lung cancer.</li>
<li>Waters Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wat#NYSE">WAT</a>) declined 9.9% to $312.79. SVB Leerink maintained Waters with a Market Perform and raised the price target from $320 to $352.</li>
<li>Silvergate Capital Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/si#NYSE">SI</a>) dropped 9.5% to $11.37 after multiple firms downgraded the stock and lowered their respective price target.</li>
</ul>
Also Check This Out <a href="https://www.benzinga.com/markets/cryptocurrency/23/01/30310858/ethereum-remains-above-this-key-level-tron-becomes-top-loser"> Ethereum Remains Above This Key Level; TRON Becomes Top Loser</a>

Why Spruce Biosciences Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Friday's Mid-Day Session

WIIM

CDAY

DOCU

GDYN

MVIS

PYCR

RELL

Shares of companies in the broader tech sector are trading lower amid a selloff in tech and growth stocks on rate concerns.

Comments

Schmitt Industries

Schmitt Industries (SMIT) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga